ArticleJournal of translational medicine2024

Synergistic effect of FOXM1 and BCL-2 inhibition in a preclinical treatment study on multiple myeloma.

Vivian Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.